PGI13: FACTORS ASSOCIATED WITH PHYSICIAN KNOWLEDGE OF WHETHER PRESCRIPTION DRUGS ARE ON FORMULARY  by Shih, YCT & Sleath, B
126 Abstracts
role in refractory GERD patients. The purpose of this
cross-sectional survey study is to estimate the percentage
of patients actively treated with PPI’s (omeprazole and
lansoprazole), who perceive control of their symptoms.
The Gastrointestinal Symptom Rating Scale (GSRS), a
validated rating scale to assess GERD patients’ quality of
life, was utilized. The study hypothesis is that 80% of the
patients will perceive their symptom control is very good
or excellent. METHODS: An unblinded self-adminis-
tered questionnaire, including the GSRS, was mailed to
300 patients who were currently receiving GERD mainte-
nance therapy with a PPI. Patients were asked questions
regarding the duration and severity of symptoms, dosing
of medication, contributing lifestyle factors and debilita-
tion of disease. RESULTS: 153 questionnaires were re-
turned fully completed, a 51% response rate. The sur-
veyed patients were 60  14 years with 89% of
respondents being male. Of the PPI’s prescribed 86% and
14% were lansoprazole and omeprazole respectively. The
median total score of the GSRS was 19, representing mild
to moderate patient symptomatology. CONCLUSIONS:
66% of respondents treated with currently prescribed
PPI’s had very good or excellent symptom control, how-
ever the need exists for a more effective PPI for adequate
symptom control in 34% of patients.
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OBJECTIVE: Prescription drug formularies have been
used by many pharmacy benefit managers (PBMs) as a
tool to control the rising costs of prescription drugs and
became increasingly popular since the 1990s. Despite its
popularity, little is known about how familiar physicians
are with what prescriptions are on formulary. This study
examines factors associated with physician knowledge of
formulary. METHODS: The National Ambulatory Med-
ical Care Survey (NAMCS) is a data series of annual sur-
vey of a national representative sample of physician of-
fice visits. It provides up to six medications associated
with each office visit. The 1998 NAMCS collected infor-
mation regarding the formulary status (yes, no, do not
know, or not applicable) of each medication and pro-
vided a unique opportunities to assess physicians’ knowl-
edge of formulary. Univariate analyses as well as multi-
variate logit model were used to examine the association
between physician knowledge of formulary and types of
visits, physician specialty and practice locations. RE-
SULTS: On average, 47% of physicians did not know
whether the drug they prescribed was on formulary. Phy-
sicians whose patients belonged to an HMO and were
paid by capitation were seven times more likely to know
whether a drug was on formulary, compared to those
whose patients were neither in an HMO nor capitated.
Physicians in the South were 1.7 times more likely to
know than those in the West, whereas the odd-ratios was
0.7 for those in the Midwest. Neither physician specialty
(primary care physician versus specialist) nor patient his-
tory (new versus established patient) was found to be sig-
nificantly associated with physician knowledge of formu-
lary. CONCLUSIONS: It is important for PBMs to find
mechanisms to increase physician awareness of whether a
patient’s medications are on formulary. Improving physi-
cians’ understanding of what medications were on for-
mulary could potentially decrease prescription drug costs
for health care plans and patients.
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OBJECTIVES: To assess the association between hospi-
tal costs and the appropriateness of empirical antibiotic
treatment for community-acquired intra-abdominal in-
fection. METHODS: Patients were identified from hospi-
tal discharges from three hospitals for 1993 to 1997.
Medical records were obtained to validate the diagnosis
and obtain details of antibiotic therapy and its outcome.
Valid cases had macroscopic evidence of intra-abdominal
infection at operation, therefore all cases had surgical
control of infection in addition to antimicrobial therapy.
Appropriateness of empirical therapy was assessed from
the results of in-vitro sensitivity tests (culture positive
cases) and compliance with local antibiotic policies (cul-
ture negative cases). RESULTS: We identified 294 valid
cases of intra-abdominal infection of whom 162 (55%)
were culture positive. Appropriate antibiotic treatment
was associated with significantly shorter length of stay
and lower investigation costs for patients with positive
cultures but not for patients with negative cultures or no
test/result (data not shown). Culture ve cases, appropri-
ate (n  129) vs inappropriate (n  33): mean length of
stay 12 vs 22 days, p  0.0007 boot strap t test, mean in-
vestigation cost £250 vs £409 p  0.04, mean antibiotic
cost £138 vs £128 p  0.9. A log transformed linear re-
gression analysis was carried out on the cost data for the
culture positive cases adjusting for five independent vari-
ables. Inappropriate antibiotics, increasing age and a
higher number of comorbidities and previous admissions
were significantly associated with increased cost of hospi-
tal stay but not gender. This model accounted for 34% of
the variance in cost of hospital stay. For the cost of inves-
tigations inappropriate treatment, increasing age and
